Key facts
- This page summarizes Donald H. Picker's Form 4 filing for Moleculin Biotech, Inc. (MBRX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 16 Oct 2026, 21:01.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
The stock option set forth in this table vests as follows: (i) 50% on grant; and (ii) 50% in 18 equal installments over 18 months.
Footnote F2
Issued in connection with the reporting person's employment with the Company.